Molecular Testing For Cystic Fibrosis Carrier Status

Document Overview

Document Title

Molecular Testing For Cystic Fibrosis Carrier Status

Authoring Society

National Society of Genetic Counselors

Document Publication Date

Sep 1, 2013

Page Last Reviewed/Updated

May 6, 2026

Document Type

Guideline

Country of Publication

United States

Full Text Freely Available

Yes

Full Text Guideline

onlinelibrary.wiley.com/doi/10.1007/s10897-013-9636-9

Source Citation

https://doi.org/10.1007/s10897-013-9636-9

Supplemental Implementation Resources

• Patient Information
• Patient Information
• Patient Information
• Patient Information
• Patient Information
• Patient Information
• Patient Information
• Patient Information
• Patient Information
• Quick-Reference Guide
• Quick-Reference Guide

Document Scope, Criteria, and Use Cases

Document Objectives

To provide practice recommendations for genetic counselors whose clients are considering cystic fibrosis (CF) carrier testing or seeking information regarding CF molecular test results. 

Scope

Assessment and Screening, Counseling

Diseases/Conditions (MeSH)

D005820 - Genetic Testing

D003550 - Cystic Fibrosis

D000068617 - Genetic Background

D005823 - Genetics

D003550 - Cystic Fibrosis

D005820 - Genetic Testing

D000068617 - Genetic Background

D005823 - Genetics

Keywords

cystic fibrosis, genetic counselors, genetic testing

Target Patient Population

Patients who are considering cystic fibrosis carrier testing

Inclusion Criteria

Female, Male, Adolescent, Adult, Child, Older Adult

Health Care Settings

Ambulatory, Outpatient

Intended Users

Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Number of Source Documents

73

Includes peer/external review process?

Yes

Includes public comment process?

No

Methodologist involvement?

Yes

Patient involvement?

No

Includes multi-disciplinary group?

Yes

Includes systematic review?

Yes

Grades quality of strength of evidence?

Yes

Grades quality of strength of recommendation?

Yes

Includes benefits/harms analysis with recommendations?

No